Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single-dose subcutaneous injection of SHR-3045 in healthy subjects.
Official title: The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Dose Subcutaneous Injection of SHR-3045 in Healthy Subjects-A Randomized, Double-Blind, Dose-Escalating, Placebo-Controlled Phase I Study
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2025-10-08
Completion Date
2026-03
Last Updated
2025-11-17
Healthy Volunteers
Yes
Conditions
Interventions
SHR-3045 Injection
SHR-3045 injection.
SHR-3045 Placebo Injection
SHR-3045 placebo injection.
Locations (1)
The Frist Affiliated Hospital of USTC (Anhui Provincial Hospital)
Hefei, Anhui, China